Apterna
Preclinical biotech developing liver-directed RNA therapies to restore liver function for patients with liver cancer
Highlights
- New on EvolcAdded 2026-10-31
About Apterna
Apterna is a preclinical biotechnology company developing precision RNA therapeutics designed to restore liver function. Its initial focus is liver cancer surgery, where poor liver reserve can limit access to potentially curative surgery. Its lead programme is REGEN001. Future areas of interest include cirrhosis, transplant avoidance and metabolic liver disease.
The company is at an investigational stage, and its therapeutic approach is still in development. It welcomes conversations with scientific collaborators, strategic partners and investors. It has research relationships with Imperial College London and City of Hope, and works with specialist development and manufacturing partners.
Apterna was founded in 2011 and is headquartered in London. Its founders are Professor Nagy Habib, Dr Declan Doogan and Joanna Nicholls. The company lists expressions of interest across RNA and molecular biology, pharmacology and toxicology, bioinformatics, clinical operations and business development.
Product: Preclinical liver-directed RNA therapeutics; lead programme REGEN001.
Jobs at Apterna
Leadership
- Declan Doogan · Chief Medical OfficerSource: company website
- Nagy Habib · Co-Founder, Chair & CEOSource: company website
- Joanna Nicholls · Chief Operations OfficerSource: company website
More biotech & pharma companies
Arecor
Develops therapeutics for people with diabetes, obesity and other cardiometabolic diseasesNew on EvolcAspire Pharma
Specialty and niche generic medicines for patients, healthcare professionals and health systems in the UK and international marketsNew on EvolcRemote-friendlyAstute Healthcare
Wholesale distributor of medicines and FMCG health and personal care products to pharmacies, retailers and hospitals in the UKNew on EvolcAutolus
Develops engineered T-cell therapies for patients with cancer and autoimmune diseasesNew on EvolcRemote-friendlyAutomata
Lab automation hardware and software for life science labs, including workflow orchestration and configurable lab benchesNew on EvolcRemote-friendlyAvacta Life Sciences
Clinical-stage biopharma developing tumor-activated peptide drug conjugates that release cancer drugs only in tumorsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Vercel